Author

G. Gargiulo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

C. Company· 3 shared Y. Dramaretska· 3 shared B. Jiang· 2 shared M. J. Schmitt· 2 shared M. Serresi· 2 shared A. Izzo· 1 shared A. Tsankov· 1 shared B. Giotti· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

C. Company

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A Mutation-driven oncofetal regression fuels phenotypic plasticity in colorectal cancer

S. Mzoughi, M. Schwarz, X. Wang, D. Demircioglu, G. Ulukaya, K. Mohammed, F. Di Tullio, C. Company, Y. Dramaretska, M. Leushacke, B. Giotti, T. Lannagan, D. Lozano-Ojalvo, D. Hasson, A. Tsankov, , E. Guccione

This study identifies an oncofetal cell state that contributes to resistance in colorectal cancer and shows that targeting both this state and LGR5+ CSCs is needed for effective treatment.

bioRxiv · Dec 10, 2023Cancer Biology

Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses

B. Jiang, M. J. Schmitt, U. Rand, C. Company, M. Grossmann, M. Serresi, L. Cicin-Sain, G. Gargiulo

The paper identifies pharmacological modulators of epithelial immunity by analyzing SARS-CoV-2 infection responses using synthetic genetic reporters and drug screens.

bioRxiv · Nov 5, 2022Bioengineering

Logical design of synthetic cis-regulatory DNA for genetic tracing of cell identities and state changes

C. Company, M. J. Schmitt, Y. Dramaretska, S. Kertalli, B. Jiang, M. Serresi, I. Barozzi, G. Gargiulo

The paper introduces LSD, a computational framework for designing synthetic cis-regulatory DNA to mark cellular states, and demonstrates its effectiveness in identifying cell-state drivers.

bioRxiv · Nov 4, 2022Bioengineering

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1

C. Marques, T. Unterkircher, P. Kroon, A. Izzo, Y. Dramaretska, E. Kling, B. Oldrini, O. Schnell, S. Nelander, E. F. Wagner, L. Bakiri, G. Gargiulo, M. S. Carro, M. Squatrito

The paper identifies FOSL1 as a key regulator of mesenchymal glioblastoma subtype through NF1 modulation, showing its role in plasticity and aggressiveness.

bioRxiv · Nov 6, 2020Cancer Biology